Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine versus nitroglycerin for tilt test response in recurrent syncope
IRCT20170815035715N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in syncope comparing Adenosine arm with Nitroglycerin arm (2 arms). Primary endpoint: Tilt test result. Started Jul 2018; status: completed.
02
Drugs
adenosinenitroglycerin
03
Conditions
syncope
Beyond the preview
Go deeper on IRCT20170815035715N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170815035715N2.